Chicago Partners Investment Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Sell
1,880
-229
-11% -$106K 0.02% 594
2026
Q1
$1.07M Buy
2,109
+191
+10% +$97.8K 0.02% 516
2025
Q4
$1.13M Buy
1,918
+748
+64% +$425K 0.03% 431
2025
Q3
$679K Buy
+1,170
New +$511K 0.02% 548
2025
Q1
Sell
-839
Closed -$298K 971
2024
Q4
$298K Buy
+839
New +$285K 0.01% 659

Other funds holding MEDP

Chicago Partners Investment Group's MEDP Position: Q2 2026 in Review

Chicago Partners Investment Group reduced its Medpace (MEDP) stake by 11% in Q2 2026, selling an estimated $106K and leaving 1,880 shares worth $1.14M. The position accounts for 0.02% of the portfolio, ranked #594.

Chicago Partners Investment Group first reported a position in MEDP in Q4 2024 and has held it in 5 quarters since. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Chicago Partners Investment Group held 1,880 shares of Medpace worth $1.14M as of Q2 2026.
  • Chicago Partners Investment Group sold 229 Medpace shares in Q2 2026, an estimated $106K.
  • Medpace made up 0.02% of Chicago Partners Investment Group's portfolio in Q2 2026, its #594 holding.
  • Chicago Partners Investment Group first reported a position in Medpace in Q4 2024 and has held it in 5 quarters since.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.